Abnormal hyperphosphorylation of tau protein (p-tau) is a key component of NFT, especially the phosphorylation of specific Thr residues (Thr 181, 217, and 231) is a biomarker of AD pathology [71]. This evidence concerns the gene MAPT and Alzheimer disease.